Versant Capital Management’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
Other funds holding VIR
Versant Capital Management's VIR Position: Q3 2026 in Review
Versant Capital Management held its Vir Biotechnology (VIR) position steady in Q3 2026 at 2,690 shares worth $30.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1737.
Versant Capital Management first reported a position in VIR in Q1 2022 and has held it in 18 quarters since. 218 funds tracked by Wall St. Rank hold VIR as of Q3 2026.
- Versant Capital Management held 2,690 shares of Vir Biotechnology worth $30.1K as of Q3 2026.
- Versant Capital Management left its Vir Biotechnology share count unchanged in Q3 2026.
- Vir Biotechnology made up ﹤0.01% of Versant Capital Management's portfolio in Q3 2026, its #1737 holding.
- Versant Capital Management first reported a position in Vir Biotechnology in Q1 2022 and has held it in 18 quarters since.
- 218 funds tracked by Wall St. Rank held Vir Biotechnology as of Q3 2026.
Based on Versant Capital Management's 13F filing for Q3 2026, filed 2 Oct 2026.